Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00422396 · ClinicalTrials.gov registry record · NA
Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis
A NA study, sponsored by University of Michigan.
- Completed
- Registry status
- NA
- Development phase
- 60
- Enrollment target
NCT00422396 is a NA study that has completed, run by University of Michigan. The registered enrollment target is 60 participants.
The verdict
NCT00422396, a NA study, has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- NA
- Development phase
- 60 participants
- Enrollment target
Study Summary
This is a randomized placebo controlled clinical trial designed to investigate the effects of micronized fenofibrate on fasting and postprandial lipoproteins, oxidized fatty acids and lipoproteins, inflammatory mediators and thrombotic factors among hypertriglyceridemic individuals with two or more other characteristics of the metabolic syndrome.
Interventions
- DRUG Fenofibrate (drug)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2001-01 |
| Est. Completion | 2002-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00422396
The ClinicalTrials.gov registry entry for NCT00422396 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Michigan, which has 1,327 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Fenofibrate (drug) is the first listed.
NCT00422396 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00422396 about?
NCT00422396 is a clinical study titled "Effects of Micronized Fenofibrate on Fasting and Postprandial Lipoproteins, Inflammatory Mediators and Thrombosis". This is a randomized placebo controlled clinical trial designed to investigate the effects of micronized fenofibrate on fasting and postprandial lipoproteins, oxidized fatty acids and lipoproteins, inflammatory mediators and thrombotic factors among hypertriglyceridemic individuals with two or more ...
What is the current status of trial NCT00422396?
This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2001-01. Estimated completion is 2002-04.
What interventions are being tested in trial NCT00422396?
The interventions under investigation include: Fenofibrate (drug) (DRUG).
Who is sponsoring clinical trial NCT00422396?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.